The question of when and how to begin screening for breast cancer remains a critical health concern for women globally, particularly as recent data highlights the growing prevalence of the disease. In Vietnam, breast cancer has emerged as the most frequently diagnosed malignancy among women, outpacing lung and colorectal cancers. According to the GLOBOCAN 2024 report released in July 2026 by the International Agency for Research on Cancer (IARC), breast cancer accounts for over 28% of all new cancer cases among Vietnamese women, meaning roughly one in three women diagnosed with cancer is battling this specific disease.
The Silent Progression of Breast Cancer
Breast cancer is characterized by its insidious nature; in its early stages, it often develops silently, producing no discernible symptoms or physical pain. Many women mistakenly believe that medical intervention is only necessary when a lump becomes palpable or other visible abnormalities appear. However, relying on symptomatic presentation often leads to late-stage diagnoses, significantly complicating treatment pathways and reducing survival rates.
Dr. Phan Thi Hong Duc, Head of the General Internal Medicine Department at the Oncology Hospital of Ho Chi Minh City, emphasizes that the clinical appearance of a tumor is a lagging indicator. "Screening is designed specifically to detect physiological irregularities before they manifest as clinical symptoms," Dr. Duc explains. "Early detection is not merely a diagnostic milestone; it is the most effective tool we have to increase the likelihood of successful treatment, minimize the extent of surgical or chemical intervention, and drastically improve long-term survival rates."
Survival Rates and the Criticality of Timing
The correlation between the stage of detection and patient outcomes is stark. Statistical analysis indicates that the five-year survival rate for patients diagnosed with early-stage breast cancer can reach as high as 98%. Conversely, this figure drops to below 10% for patients whose cancer is identified in late or metastatic stages. If detected early, the potential for a complete recovery is estimated at between 90% and 95%.
This disparity underscores the necessity of proactive health management. Rather than waiting for external warning signs, medical professionals advocate for a tailored approach to screening based on an individual’s personal risk profile.
Risk Assessment: Who Needs Early Intervention?
The standard age for beginning routine screening is not universal. Medical professionals, including Dr. Duc, evaluate individual risk based on a comprehensive review of family history, genetic predispositions, and previous health encounters.
High-risk groups requiring closer monitoring and potentially earlier screenings include:
- Family History: Individuals with first-degree relatives (mothers, sisters, or daughters) who have been diagnosed with breast or ovarian cancer.
- Genetic Factors: Individuals carrying known gene mutations, such as BRCA1 or BRCA2, which significantly elevate the risk of developing hereditary breast cancer.
- Medical History: Patients who have undergone thoracic (chest) radiation therapy at a young age.
For these individuals, screenings may be recommended as early as age 30, or even earlier depending on the specific clinical history. In such cases, standard mammograms may be supplemented with Magnetic Resonance Imaging (MRI) or other advanced diagnostic techniques to ensure a more accurate assessment. For the general population without high-risk indicators, the screening schedule should follow clinical guidelines rather than anecdotal advice, ensuring that the intensity and frequency of testing are balanced against the patient’s actual risk level.
Warning Signs: When to Seek Immediate Attention
While regular screening is the gold standard for early detection, awareness of physical changes remains vital. Women are encouraged to perform regular self-examinations to monitor for:
- The appearance of new lumps or masses in the breast or underarm area.
- Retraction or inversion of the nipple.
- Unexplained changes in the texture or appearance of the breast skin, such as dimpling or persistent redness.
- Nipple discharge that is not related to breastfeeding.
- Significant, unexplained changes in the size or shape of the breast.
If any of these signs appear, it is imperative to seek professional medical evaluation immediately, regardless of when the next scheduled screening is due.
Institutional Initiatives and Public Health Outreach
In recognition of the 2026 World Patient Safety Day, the Oncology Hospital of Ho Chi Minh City has launched a significant public health initiative aimed at bridging the gap between screening accessibility and public awareness. Recognizing the financial and logistical barriers that often prevent women from seeking preventative care, the hospital has partnered with several organizations to provide free breast cancer screenings.
This program targets 600 women aged 25 and older, divided into two distinct sessions to ensure quality of care and efficient throughput. The first session, scheduled for October 31, 2026, includes comprehensive consultations with oncology specialists alongside the diagnostic screening. The second session will take place on November 8, 2026. Both events are being hosted at the hospital’s second facility, located at 12, 400 Street, Tang Nhon Phu Ward, Ho Chi Minh City, with operations running from 7:30 AM to 11:30 AM.
Interested participants can register via the dedicated hotline (1900 633 465) or by scanning the QR code provided on the official event promotional material. This initiative is designed not only to provide immediate testing but also to foster a culture of health awareness, helping to demystify the screening process and reduce the stigma associated with breast cancer testing.
Broader Implications for Healthcare Infrastructure
The initiative by the Oncology Hospital of Ho Chi Minh City reflects a broader, necessary shift in healthcare policy across Southeast Asia. As non-communicable diseases (NCDs) like cancer represent an increasing burden on national health budgets, the focus is shifting toward "secondary prevention"—the practice of catching diseases at a stage where they are manageable and treatable.
The economic implications of this shift are profound. Early-stage cancer treatment is significantly less resource-intensive than late-stage palliative care or complex chemotherapy regimens required for metastatic disease. By investing in widespread, systematic screening programs, the healthcare system can potentially reduce the long-term cost of care while simultaneously increasing the quality of life for the population.
Furthermore, the integration of genetic counseling into standard breast health check-ups is a developing frontier in Vietnamese oncology. As testing for mutations like BRCA1 and BRCA2 becomes more accessible, public health messaging will need to evolve to help women understand what these results mean for their long-term health, as well as the health of their families.
Conclusion: A Proactive Future
The message from the medical community is clear: breast cancer is a manageable disease when caught early, but its asymptomatic nature requires a proactive, rather than reactive, approach. By leveraging modern diagnostic technology, adhering to professional screening guidelines, and participating in public health initiatives, women can significantly alter their risk profile.
As Vietnam continues to confront the rising tide of cancer, the emphasis on education and accessible screening serves as a cornerstone for patient survival. Whether through institutional programs like those at the Oncology Hospital of Ho Chi Minh City or individual adherence to regular check-ups, the path forward is defined by the awareness that early detection is the single most powerful weapon against this disease. The battle against breast cancer is not won through a single test, but through a consistent, informed, and courageous commitment to one’s own health.
